| Drug Name | ENTYVIO (vedolizumab) |
|---|---|
| Drug Class |
Immunosuppressant
|
| Risk minimization type |
Patient Card
Healthcare provider guide
|
| Specialty (Theraputic area) |
Immunology
|
| Risk |
risk of Progressive multifocal leukoencephalopathy (PML) |
| Patient card |
|
| Health care provider guide |
|